Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S26 pseudogene 42 (RPS26P42) is a non-protein-coding processed pseudogene related to the ribosomal protein S26 gene and is found in the human genome[7][4]. Pseudogenes arise from duplication or retrotransposition events of parent genes and typically do not encode functional proteins; RPS26P42 does not contribute directly to ribosome function or cellular biology. Pseudogenes may be useful for evolutionary and genomic studies, but RPS26P42 is not a current focus of biomedical research or drug discovery. For functional and disease-relevant information, the parent gene "ribosomal protein S26" (RPS26) should be considered instead[4][3][7].
None. No mechanisms of action are described for drugs targeting or mediated by this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein S26 pseudogene 42 (RPS26P42).